tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

News

All

Editors' Picks

Stocks

Indices

Market Movers

Commodities

Cryptocurrencies

Forex

Presentations

Earnings

Transcripts

Technical Analysis

Economic Indicator

Other

Unusual Machines (UMAC) Q3 2026 Earnings Call: Revenue Rises 551%, Q4 Target Held at $25M

Unusual Machines Q3 2026 revenue rose 551% to $13.9 million as management maintained its $25 million Q4 target and expanded drone production capacity.
iconUnusual Machines Inc
TradingKey
Fri, Nov 6

Upland Software (UPLD) Q3 2026 Earnings Call: Churn Weighs on Revenue, Margin Plan Advances

Upland Software Q3 2026 revenue fell 6% to $47.5 million, while adjusted EBITDA reached $12.6 million. Review churn, debt reduction and guidance.
iconUpland Software Inc
TradingKey
Fri, Nov 6

Stabilis Solutions (SLNG) Q3 2026 Earnings Call: Data Center Contract Drives 2027 Outlook

Stabilis Solutions Q3 2026 revenue rose 25% sequentially to $14.8 million as data center demand grew, while a $200 million contract supports its 2027 outlook.
iconStabilis Solutions Inc
TradingKey
Fri, Nov 6

The ONE Group (STKS) Q3 2026 Earnings Call: Margin Expansion and Cash Flow Growth

The ONE Group’s Q3 2026 earnings call covered 190-basis-point restaurant margin expansion, $41.8 million of YTD operating cash flow and updated guidance.
iconOne Group Hospitality Inc
TradingKey
Fri, Nov 6

Purple Innovation (PRPL) Q3 2026 Earnings Call: Revenue Falls 19%, EBITDA Outlook Cut

Purple Innovation Q3 2026 revenue fell 19% to $96.5 million. PRPL maintained revenue guidance but cut its adjusted EBITDA outlook to $15 million-$20 million.
iconPurple Innovation Inc
TradingKey
Fri, Nov 6

Cognition Therapeutics (CGTX) Q3 2026 Earnings Call: DLB Phase III Plan Advances

Cognition Therapeutics’ Q3 2026 earnings call detailed its FDA-aligned zervimesine DLB Phase III plan, $31.5 million cash balance and 2027 milestones.
iconCognition Therapeutics Inc
TradingKey
Fri, Nov 6

aka Brands (AKA) Q3 2026 Earnings Call: U.S. Sales Rise 14%

aka Brands’ Q3 2026 earnings call covers 9.7% sales growth, a 60.1% gross margin, stronger U.S. demand and updated full-year guidance.
iconAKA Brands Holding Corp
TradingKey
Fri, Nov 6

Ascent Industries (ACNT) Q3 2026 Earnings Call: Sales Rise 37.8%, EBITDA Margin Hits 13%

Ascent Industries Q3 2026 sales rose 37.8% to $27.1 million, adjusted EBITDA reached $3.5 million, and its sales pipeline totaled about $135 million.
iconAscent Industries Co
TradingKey
Fri, Nov 6

Accuray (ARAY) Fiscal Q1 2027 Earnings Call: Service Margins Rise as Product Revenue Falls

Accuray fiscal Q1 2027 revenue fell 8% to $86.5 million, while service revenue rose 4%, service margin reached 35.1% and adjusted EBITDA improved.
iconAccuray Inc
TradingKey
Fri, Nov 6

Zevia (ZVIA) Q3 2026 Earnings Call: Sales Rise 18.4%, Guidance Raised

Zevia Q3 2026 net sales rose 18.4% to $48.3 million, its adjusted EBITDA loss narrowed, and management raised full-year sales and profit guidance.
iconZevia PBC
TradingKey
Fri, Nov 6

Zillow Group (Z) Q3 2026 Earnings Call: Rentals Growth Offsets Housing Pressure

Zillow Group Q3 2026 revenue rose 7% to $724 million as Rentals grew 26%. Management guided Q4 revenue to $635 million-$665 million amid higher rates.
iconZillow Group Inc
TradingKey
Fri, Nov 6

Xeris Biopharma (XERS) Q3 2026 Earnings Call: Revenue Guidance Raised

Xeris Biopharma Q3 2026 revenue rose 44% to $107.2 million as Recorlev surged 93%. Management raised 2026 guidance and its 2030 outlook.
iconXeris Biopharma Holdings Inc
TradingKey
Fri, Nov 6

Chiron Real Estate (XRN) Q3 2026 Earnings Call: Senior Housing Expansion and Asset Sales

Chiron Real Estate’s Q3 2026 earnings call covered $0.75 core FFO, seniors housing lease-up, $430 million of investments and planned medical asset sales.
iconGlobal Medical REIT Ord Shs
TradingKey
Fri, Nov 6

Wynn Resorts (WYNN) Q3 2026 Earnings Call: Macau EBITDAR Reaches $255.3M

Wynn Resorts’ Q3 2026 earnings call covered $255.3 million in Macau EBITDAR, Las Vegas hold pressure and the September 2027 Al Marjan opening.
iconWynn Resorts Ltd
TradingKey
Fri, Nov 6

WillScot (WSC) Q3 2026 Earnings Call: Modular Growth Supports 2027 Outlook

WillScot’s Q3 2026 earnings call covered 6% revenue growth, stronger modular demand, updated 2026 guidance and an initial 2027 growth outlook.
iconWillscot Holdings Corp
TradingKey
Fri, Nov 6

VSE Q3 2026 Earnings Call: Record EBITDA and Higher Full-Year Guidance

VSE Q3 2026 revenue rose 91% to $541 million, adjusted EBITDA reached $107 million, and management raised full-year growth and margin guidance.
iconVSE Corp
TradingKey
Fri, Nov 6

Watts Water Technologies (WTS) Q3 2026 Earnings Call: Data Centers Drive Record Sales and Raised Guidance

Watts Water Technologies Q3 2026 sales rose 19% to $728 million as data center demand drove margin expansion and higher full-year guidance.
iconWatts Water Technologies Inc
TradingKey
Fri, Nov 6

Viasat (VSAT) Fiscal Q2 2027 Earnings Call: DAT Growth and Higher Free Cash Flow Outlook

Viasat fiscal Q2 2027 revenue rose 3% as DAT grew 20%. Management raised free cash flow guidance above $225 million and cut its CapEx outlook.
iconViasat Inc
TradingKey
Fri, Nov 6

Viemed Healthcare (VMD) Q3 2026 Earnings Call: Revenue Growth and Updated Guidance

Viemed Healthcare Q3 2026 earnings call: revenue rose 12.2% to $80.7 million as sleep therapy expanded, while management updated full-year guidance.
iconViemed Healthcare Inc
TradingKey
Fri, Nov 6

Vera Therapeutics (VERA) Q3 2026 Earnings Call: TRUTAKNA Launch and ORIGIN 3 Results

Vera Therapeutics Q3 2026 earnings call: TRUTAKNA generated $10.3 million in revenue, reached about 700 patient start forms, and advanced toward full FDA approval.
iconVera Therapeutics Inc
TradingKey
Fri, Nov 6
Featured Tools
marketing_marketsTitleMarketscalendar_economicCalendarEconomic Calendarsearch.intelligent.strategySmartPicksarticle_asider_weekly_reportWeekly Report
Popular Instruments
link
Name
Price
Chg%
US30
US30
US30
--
--
NAS100
NAS100
NAS100
--
--
SPX500
SPX500
US500
--
--
Top News
link
Nasdaq Extends Gains by 1.6%, SOX Surges Over 5%; Tech Stocks Lead Market as CoreWeave Soars Over 25% Post-Earnings
US October PPI Preview: Fed Rate Hike Expectations Rise, PPI May Be Key Variable; How Will US Stocks, Dollar, and Gold Move?
Dow Jones futures remain steady amid hawkish Fed rate outlook, Nvidia leadership turmoil
Nvidia Falls Over 7% Premarket, AMD and Broadcom Buck Trend to Gain Over 2%: Jensen Huang’s Future May Drive Customers to Diversify Chip Purchases
Memory Stocks Surge, Micron Jumps 11% as Morgan Stanley Says Valuation Pullback Improves Memory Stocks' Risk-Reward
Market Movers
link
Delta Air Lines Inc Stock (DAL) Moved Down by 5.05% on Nov 12: What Investors Need To Know
48 minutes ago
DAL
--
Keurig Dr Pepper Inc Stock (KDP) Moved Down by 7.05% on Nov 12: Key Drivers Unveiled
48 minutes ago
KDP
--
Moderna Inc Stock (MRNA) Moved Down by 5.50% on Nov 12: Drivers Behind the Movement
2 hours ago
MRNA
--
HubSpot Inc Stock (HUBS) Moved Up by 7.40% on Nov 12: Facts Behind the Movement
2 hours ago
HUBS
--
Summit Therapeutics Inc Stock (SMMT) Moved Down by 7.27% on Nov 12: Drivers Behind the Movement
2 hours ago
SMMT
--
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy